Enhancing microRNA activity through increased endosomal release mediated by nigericin

EA Orellana, AM Abdelaal, L Rangasamy… - … Therapy Nucleic Acids, 2019 - cell.com
The therapeutic promise of small-RNA therapeutics is limited, not only by the lack of delivery
vehicles, but also by the inability of the small RNAs to reach intracellular compartments …

Suppression of SIN3A by miR-183 Promotes Breast Cancer Metastasis

ML Davenport, MR Davis, BN Davenport… - Molecular Cancer …, 2022 - aacrjournals.org
Recent work has established that SWI-independent-3 (SIN3) chromatin modification
complexes play key roles in cancer progression. We previously demonstrated that …

Development of an RNA-based Cancer Therapeutic Restoring Tumor Suppressor microRNA

S Myoung - 2021 - hammer.purdue.edu
Based on the knowledge that miRNAs are dysregulated in diseases such as cancer, there
have been multiple attempts to develop miRNA-based cancer therapeutics. However …

Revealing the high propensity of RNAs to non-specifically bind drug-like small molecules

ML Kelly, CC Chu, H Shi, LR Ganser, HP Bogerd… - bioRxiv, 2020 - biorxiv.org
Identifying small molecules that selectively bind a single RNA target while discriminating
against all other cellular RNAs is an important challenge in RNA-targeted drug discovery …

Enhancing miRNA therapeutic efficacy through combinatorial targeting and vehicle free delivery

EA Orellana - 2018 - search.proquest.com
New alternative therapies to treat cancer have emerged such as the use of small molecules
that target key oncogenic drivers. For instance, clinically relevant tumor suppressive …